Stocks · News reference
SS Innovations (NASDAQ:SSII) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. The company reported quarterly sales of $13.940 million which beat the
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
SS Innovations International, Inc. demonstrated its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console through successful remote surgeries at two major medical conferences in October 2026.
Filed: 2026-10-26 AccNo: 0001213900-26-112292 Size: 279 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible
The article profiles two rare microcap companies generating majority sales outside the US: SS Innovations International (SSII), a surgical robotics company with 87% of sales from India showing strong 39.4% YOY revenue growth but facing cash burn issues, and Iveda Solutions (IVDA), an AI-driven smart city technology provider with 91% of sales from Taiwan that generates lumpy, project-driven revenue from government contracts.